Invest in

Fighting Fat

3.3%
1.0%
0.0%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
3.3%
1.0%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
52.9% Diabetes Care 2.6%
17.5% Merck & Company Inc. (new) MRK 27.0%
15.2% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 9.2%
13.3% Novo Nordisk A/S NVO 32.2%
2.8% Astrazeneca Plc ADR AZN 4.9%
2.4% Alkermes plc ALKS 13.1%
1.8% Integer Holdings Corporation ITGR --
40.9% Weight Management 52.4%
18.8% NutriSystem Inc NTRI 88.6%
9.3% MEDIFAST INC MED 45.3%
4.5% Weight Watchers International Inc WTW 17.0%
3.7% Nu Skin Enterprises Inc. (A) NUS 61.7%
2.2% USANA Health Sciences Inc. USNA 2.0%
1.5% Vitamin Shoppe Inc VSI 26.1%
1.0% GNC Holdings Inc. Class A GNC 59.2%
6.2% Weight Loss Drugs 12.4%
6.2% Arena Pharmaceuticals Inc. ARNA 12.4%

Quotes delayed 15 mins. Currently Jan 17, 2017 4:18:19 PM. Fields are marked with -- when data is unavailable.